Friedreich Ataxia Scientific News
Friedreich Ataxia and close related scientific news. Topics related to rare diseases.
Wednesday, December 10, 2025
Eli Lilly (LLY) Completes Acquisition of Adverum Biotechnologies
Eli Lilly (LLY) Completes Acquisition of Adverum Biotechnologies. GuruFocus News 12/09/2025.
This acquisition enhances Eli Lilly's portfolio, which also includes promising candidates for retinitis pigmentosa and Friedreich's ataxia.
Eli Lilly (LLY) Completes Acquisition of Adverum Biotechnologies
‹
›
Home
View web version